Taiwan - Delayed Quote TWD

Bonraybio Co., Ltd. (6955.TW)

164.00
+4.00
+(2.50%)
At close: 1:30:03 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Zhenteng Xu Chairman & GM -- -- --
Ms. Peizhen Yang Deputy GM of Accounting & Administration and Head of Corporate Governance & Information Security -- -- --
Mr. Yingzhi Liao Executive VP and Head of R&D -- -- --

Bonraybio Co., Ltd.

No. 118, Gongye 9th Road
4th Floor Dali Dist.
Taichung, 41280
Taiwan
886 4 2491 2385 https://bonraybio.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

Bonraybio Co., Ltd., a development stage company, manufactures medical instruments and solutions for the male infertility market. The company provides LensHooke X12 PRO semen analysis systems; and LensHooke X1 PRO semen quality analyzers. It also offers consumables, such as CS3 semen test slides; CA0/CA1 sperm separation solutions; and CS1 semen test cassettes. In addition, the company provides X QC Reticles, X QC video tools, and X QC beads; sperm DNA fragmentation test kits; and S10 data consolidation software. Bonraybio Co., Ltd. was founded in 2015 and is based in Taichung, Taiwan.

Corporate Governance

Bonraybio Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

March 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers